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Localized Proton MR Spectroscopic
Detection of Nonketotic Hyperglycinemia
in an Infant
Nonketotic hyperglycinemia (NKH) is a rare metabolic brain disease caused by
deficient activity of the glycine cleveage system. Localized proton MR spec-
troscopy (echo-time 166 msec), performed in an infant with the typical clinical and
biochemical features of neonatal NKH, showed a markedly increased peak inten-
sity at 3.55 ppm, which was assigned to glycine. Serial proton MR spectrosocpic
studies indicated that glycine/choline and glycine/total creatine ratios correlated
closely with the patient’s clinical course. Proton MR spectroscopy was useful for
the non-invasive detection and monitoring of cerebral glycine levels in this infant
with NKH.
lycine is the simplest of the amino acids but is known to have important
cerebral functions, acting as both a neurotransmitter and neuromodulator
(1, 2). Although a number of other metabolic fates are possible for
glycine, the major catabolic pathway is through the glycine cleavage system, a com-
plex enzyme system found within the inner mitochondrial membrane of the liver, kid-
ney, and brain. 
Nonketotic hyperglycinemia (NKH) is an autosomal recessive disorder caused by a
deficienct glycine cleavage system, and generally results in elevated glycine levels in
urine, blood, and cerebrospinal fluid (CSF). Such increases are harmless in blood but
can cause extensive neuronal damage in neonatal brain, via N-methyl-D-aspartate glu-
tamate receptor-mediated exitotoxicity (2). Infants with NKH are usually symptomatic
within the first 48 hours, and after initial myoclonic or generalized seizure, rapid pro-
gression to coma occurs, often with apnea. Most patient die during the neonatal peri-
od, despite intensive care. 
A search of the literature brought to light only three reports describing the applica-
tion of proton magnetic resonance spectroscopy (MRS) to NKH (3-5). Each stated that
long echo-time MRS detected a prominent peak at 3.5 ppm, which was assigned to
glycine. In this case report, we describe our experience of MRS in an infant with NKH.
CASE REPORT
A male baby, delivered normally and spontaneously after a full-term pregnancy,
was well during the first 28 hours of life. He then became lethargic and hypotonic, and
the shallow respiration which began at that point progressed to intermittent apnea, re-
quiring mechanical ventilation. On the 4th day, brain computed tomography and ultra-
sonography were performed, to exclude the possibility of hemorrhage in the posterior
cranial fossa: the findings were normal. On the 5th day, amino acid analysis of the CSF
and plasma was requested, to exclude the possibility of metabolic disorders, and on
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Gthe 6th day, brain magnetic resonance (MR) imaging and
spectroscopy were performed using a 1.5-tesla system (GE
Signa, Milwaukee, Wis., U.S.A.). Again, the imaging find-
ings were normal. 
Using a single-voxel stimulated-echo acquisition mode
(STEAM) sequence (repetition time / echo time / mixing
time, 3000 / 166 / 13.7; number of excitations, 96; spectral
width 2500 Hz; number of points, 2048; voxel size, 2×2
×2 cm), proton MR spectra of the right parietal white mat-
ter were obtained. The raw data were post-processed by
water-referenced correction of the eddy current effect,
Lorenz-to-Gauss transformation, Gaussian line broadening
of 0.5 Hz, zerofilling of 8K, Fourier transformation, and
zero-order phasing of the transformed spectra. Major spec-
tral peaks occurring at 2.01, 3.03, 3.22 and 3.55 ppm were
assigned to N-acetylaspartate (NAA), creatine and phos-
phocreatine (total Cr), choline-containing compounds
(Cho), and glycine, respectively (3, 6). The spectra ob-
tained were compared with those from an age-matched
control subject (Fig. 1). The patient’s MR imaging findings
were normal (Fig. 2A), but his spectrum revealed that the
peak intensity, observed at 3.55 ppm, had increased
markedly, and this was assigned to glycine. Glycine/Cho
and glycine/total Cr ratios were found to be 1.58 and 2.42,
respectively (Fig. 2B). 
CSF and plasma amino acid analysis revealed glycine
levels of 184 (normal, < 13) nmol/mL and 1411 (normal,
232 740) nmol/mL, respectively. The CSF: plasma glycine
concentration ratio was 0.13 (normal, < 0.02). The results
of amino acid analysis and other laboratory tests indicated
NKH, and on the basis of this diagnosis, the patient was
treated with dextromethorphan (8.5 mg/kg/day) and sodi-
um benzoate (300 mg/kg/day, intravenous infusion), fol-
lowed by a double-volume exchange transfusion, peri-
toneal dialysis and total parenteral amino acid-free nutri-
tion. After intensive medical treatment, his respiration and
consciousness level improved slowly over several days,
and on the 12th day, follow-up amino acid analysis re-
vealed decreased CSF and plasma glycine concentrations
of 69 and 346 nmol/mL, respectively. On the same day,
follow-up MRS of the same parietal white matter showed
decreased glycine/Cho (1.05) and glycine/total Cr (1.31)
ratios, in accordance with decreased CSF and plasma
glycine concentrations (Fig. 2C).
After amino acid (0.5 g/kg/day) was added to the par-
enterally administered nutritional mix, the patient again
developed seizure-like motion and intermittent apnea.
Over several days, he developed intractable generalized
tonic-clonic seizure and his clinical condition deteriorated
rapidly, requiring mechanical ventilation. Final follow-up
MRS on the 17th day revealed, in comparison with the sec-
ond MRS study, a prominently increased glycine/Cho ratio
(1.80), a slightly increased glycine/total Cr ratio (1.60) and
a newly occorring lactate, at 1.3 ppm (Fig. 2D). He expired
on the 20th day.
DISCUSSION
NKH is a rare metabolic brain disease, though is well
known to neonatologists and pediatricians. In more than
80 % of NKH patients, the condition presents during the
neonatal period. Because most patients die at this time,
there have been very few neuro-imaging studies. Press et
al. (7) reported that in seven patients with NKH, MR imag-
ing studies revealed progressive atrophy, abnormal thin-
ning of the corpus callosum, and decreased or absent
myelination in the supratentorial white matter. These mor-
phologic changes can be observed in patients who survived
the neonatal period, and may be a late sequela of previous
metabolic brain damage. In the acute phase of this disease,
routine brain MR imaging findings are usually normal, de-
spite serious clinical symptoms.
MRS has, during the last decade, been applied extensive-
ly to various kinds of metabolic brain diseases, in the hope
of detecting any specific abnormal metabolites. In the ma-
jority of such diseases, however, the findings have been
non-specific, especially from a diagnostic point of view (8).
NKH is one of the few metabolic brain diseases in which
MRS can detect a specific metabolite that accumulates in
the brain. In our case, using long echo-time (166 msec)
STEAM MRS, we observed that glycine concentration in-
creased, peaking at 3.55 ppm (Fig. 2B-D). Because ab-
solute quantification of metabolite concentrations was not
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Fig. 1. A control spectrum of stimulated-echo acquisition mode
(STEAM) sequence (TR/TE, 3000/166) obtained at the parietal
white matter of a one-month-old infant with neonatal seizure, for
comparison. NAA, N-acetylaspartate; tCr, total creatine; Cho,
choline-containing compoundsfeasible, we used glycine/Cho and glycine/total Cr ratios,
as determined at serial MRS, to estimate cerebral glycine
levels. After intensive medical treatment and some symp-
tomatic improvement, glycine/Cho decreased from 1.58 to
1.05, in accordance with a decrease in CSF glycine from
184 to 69 nmol/mL. After symptomatic aggravation,
glycine/Cho increased again, from 1.05 to 1.80, reflecting
close correlation between glycine/Cho levels and the clini-
cal status of the patient. The glycine/total Cr ratio tended
to be similar to that of glycine/Cho, and in this respect,
Heindel et al. (3) reported good correlation between
glycine/Cho, glycine/total Cr, the glycine concentration es-
timated by MRS, and clinical findings. Suzuki et al. (4) re-
ported that the time course of glycine/total Cr correspond-
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Fig. 2. Proton MR imaging and spectra obtained from an infant with nonketotic hyperglycinemia. All spectra are scaled individually and
cannot be directly compared.
A. Axial T1-weighted (600/16) image obtained with a spin-echo sequence and 18-cm field of view, 256 x 192 matrix, and 5-mm contigu-
ous sections, with the voxel location as indicated for proton MR spectroscopy.
B. A spectrum obtained from the parietal white matter shows a prominent singlet at 3.55 ppm (arrow), which is assigned to glycine. The
peak intensity of glycine is much higher than that of Cho (glycine/Cho, 1.58) and of tCr (glycine/tCr, 2.42).
C. A follow-up spectrum obtained after treatment and symptomatic improvement shows a slightly decreased peak glycine intensity. The
observed peak intensity is similar to that of Cho (glycine/Cho, 1.05) and slightly higher than that of tCr (glycine/tCr, 1.31).
D. A final spectrum, obtained after symptoms worsened, shows a markedly increased peak glycine intensity. The observed peak intensi-
ty is again much higher than that of Cho (glycine/Cho, 1.80) and of tCr (glycine/tCr, 1.60), and peak lactate intensity has increased to
1.33 ppm.
AB
CDed to changes in plasma and CSF glycine levels, and Gabis
et al. (5) reported that glycine levels measured by MRS
corresponded to changes in plasma glycine levels. Our re-
sults are similar to those of previous reports and we agree
with the opinion that MRS can be used as a non-invasive
diagnostic or monitoring tool in patients with NKH. The in-
creased lactate peak observed in the final spectrum (Fig. 2
D) may reflect anaerobic glycolysis of brain tissue, proba-
bly caused by respiratory difficulty and hypoxia. In our
case, it is difficult to draw definite conclusions regarding
changes in NAA, total Cr, and Cho levels. In order to clari-
fy changes in cerebral metabolites occurring in NKH, ab-
solute quantification of their concentrations may be neces-
sary.
The clinical outcome of neonatal NKH may depend on
the severity of the involved enzyme defect. Most neonatal
forms of the disorder are usually fatal despite intensive
medical treatment, but in some transient forms, the out-
come of appropriate treatment is generally excellent (9).
These milder or atypical forms of NKH usually present a
greater diagnostic challenge (10), however, and close mon-
itoring of their clinical course and glycine levels may be
necessary even after the condition is diagnosed. In this situ-
ation, MRS can be used as a non-invasive diagnostic or
monitoring tool.
In summary, our case shows the typical clinical, laborato-
ry and MRS features of neonatal NKH. The most charac-
teristic feature of MRS was a marked increase in peak
glycine intensity, to 3.55 ppm, in the spectra obtained us-
ing a long echo-time. We believe that in patients with
NKH, MRS not only provides diagnostic information but is
also a suitable noninvasive monitoring tool.
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